Govt caps margin at 30 pc of MRP on non-scheduled cancer drugs; patients may save Rs 2,500 crore annually

New Delhi, October 9 (IANS): The government has expanded price controls on cancer medicines to curb excessive pricing and reduce out-of-pocket expenses for patients, according to an official statement.The Ministry of Chemicals and Fertilisers said it caps margins on the supply and sale of non-sched…